---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-017873"
form_type: "8-K"
ticker: "TVGN"
cik: "0001860871"
company_name: "Tevogen Bio Holdings Inc."
filed_at: "2025-07-03T23:59:59+00:00"
generated_at: "2026-05-18T09:30:40.756250+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Tevogen Bio enters $50M at-the-market equity sales agreement with A.G.P.

## Summary
- Sales agreement allows issuance and sale of up to $50M of common stock from time to time.
- Sales will be made through A.G.P./Alliance Global Partners as agent at market prices.
- Offering conducted under effective shelf registration statement (File No. 333-288218).
- Company pays agent a commission on gross proceeds and provides customary indemnification.
- Company is not obligated to sell any shares and may terminate the agreement at any time.

## SEC filing metadata
- accession: 0001641172-25-017873
- form_type: 8-K
- ticker: TVGN
- cik: 0001860871
- company_name: Tevogen Bio Holdings Inc.
- filed_at: 2025-07-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860871/000164117225017873/0001641172-25-017873-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860871/000164117225017873/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-017873
- JSON: https://secwatch.observer/filing/0001641172-25-017873.json
- Plain text: https://secwatch.observer/filing/0001641172-25-017873.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.